Procaps Group S.A. (NASDAQ:PROC) Short Interest Update

Procaps Group S.A. (NASDAQ:PROC) was the target of a large increase in short interest during the month of November. As of November 15th, there was short interest totalling 113,800 shares, an increase of 455.1% from the October 31st total of 20,500 shares. Based on an average trading volume of 68,700 shares, the days-to-cover ratio is presently 1.7 days. Currently, 0.6% of the shares of the stock are short sold.

Procaps Group Trading Down 27.8 %

Shares of PROC stock traded down $0.58 on Friday, reaching $1.51. The company’s stock had a trading volume of 105,883 shares, compared to its average volume of 31,129. The stock’s fifty day simple moving average is $1.72 and its 200-day simple moving average is $2.13. Procaps Group has a 1 year low of $0.50 and a 1 year high of $4.95.

About Procaps Group

Procaps Group SA develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory.